Drug ID: | NPD1699 |
Drug Name: | |
Molecular Formula: | C15H18O5 |
Canonical SMILES: | OC(=O)CC1Cc2c(O1)c(C)c(c(c2C)OC(=O)C)C |
Standard InCHI: | InChI=1S/C15H18O5/c1-7-8(2)15-12(5-11(20-15)6-13(17)18)9(3)14(7)19-10(4)16/h11H,5-6H2,1-4H3,(H,17,18) |
Standard InCHIKey: | QLWBKUUORSULMI-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB007588 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 278.12 |
ALogP | 1.4977 |
MLogP | 2.56 |
XLogP | 1.879 |
HDA | 3 |
HBD | 1 |
Rotatable Bonds | 9 |
TPSA | 72.83 |
RO5 Violation | 0 |